Cargando…

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care

BACKGROUND: As prostate cancer (PCa) screening decisions often occur in outpatient primary care, a brief tool to help the PCa screening conversation in busy clinic settings is needed. METHODS: A previously created 9-item tool to aid PCa screening discussions was tested in five diverse primary care c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misra-Hebert, Anita D., Hom, Grant, Klein, Eric A., Bauman, Janine M., Gupta, Niyati, Ji, Xinge, Stephenson, Andrew J., Jones, J. Stephen, Kattan, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031706/ https://www.ncbi.nlm.nih.gov/pubmed/30003062 http://dx.doi.org/10.3389/fonc.2018.00238

Ejemplares similares

Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter
por: Misra-Hebert, Anita D., et al.
Publicado: (2016)

Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool
por: Pantalone, Kevin M., et al.
Publicado: (2023)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
por: Pantalone, Kevin M., et al.
Publicado: (2019)

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer
por: Nguyen, Carvell T., et al.
Publicado: (2012)

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease
por: Pantalone, Kevin M., et al.
Publicado: (2018)

Association between shared medical appointments and weight loss outcomes and anti‐obesity medication use in patients with obesity
por: Shibuya, Kelly, et al.
Publicado: (2020)

Protons, Photons, and the Prostate – Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?
por: Schiller, Kilian C., et al.
Publicado: (2016)

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model
por: Pantalone, Kevin M., et al.
Publicado: (2020)

Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients
por: Sigurdson, Samantha S., et al.
Publicado: (2020)

Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2020)

COVID-19 Home Monitoring After Diagnosis and Health Care Utilization in an Integrated Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2021)

Implementation Experience with a 30-Day Hospital Readmission Risk Score in a Large, Integrated Health System: A Retrospective Study
por: Misra-Hebert, Anita D., et al.
Publicado: (2022)

Assessment of Physician Priorities in Delivery of Preventive Care
por: Zhang, Jessica J., et al.
Publicado: (2020)

Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer
por: Kattan, Michael W., et al.
Publicado: (2020)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
por: Karnes, R. Jeffrey, et al.
Publicado: (2018)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
por: Assi, Tarek, et al.
Publicado: (2020)

Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy
por: Spees, Colleen K., et al.
Publicado: (2015)

Development of a Nomogram Model Predicting Current Bone Scan Positivity in Patients Treated with Androgen-Deprivation Therapy for Prostate Cancer
por: Gotto, Geoffrey T., et al.
Publicado: (2014)

Accommodation with anticancer drug shortage: A Lebanese harmful solution
por: Kattan, Clarisse, et al.
Publicado: (2023)

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
por: Young, Sympascho, et al.
Publicado: (2021)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancer
por: Liu, Xiang, et al.
Publicado: (2022)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening
por: Alam, Ridwan, et al.
Publicado: (2017)

Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis
por: Rao, Srinivasa R., et al.
Publicado: (2020)

Angiosarcoma of the Bladder: Review of the Literature and Discussion About a Clinical Case
por: Gerbaud, Florian, et al.
Publicado: (2017)

Closing the gap: National Argentinian discussion forum on paediatric brain tumours
por: Baroni, Lorena V., et al.
Publicado: (2023)

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system
por: Pantalone, Kevin M, et al.
Publicado: (2017)

Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease
por: Cooper, Shawna A., et al.
Publicado: (2022)

Symptom screening in paediatrics tool for screening multiple symptoms in Brazilian patients with cancer: a cross-sectional validation study
por: Cadamuro, Sandra de Andrade, et al.
Publicado: (2019)

The Hypothetical Rabbit
por: Kattan, Michael W.
Publicado: (2016)

Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?
por: Giannarini, Gianluca, et al.
Publicado: (2014)

Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool
por: Lo, Nicholas, et al.
Publicado: (2023)

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer
por: Chung, Ivy, et al.
Publicado: (2021)

Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer
por: Shen, Yanting, et al.
Publicado: (2021)

Effectiveness of One-Stop Screening for Colorectal, Breast, and Prostate Cancers: A Population-Based Feasibility Study
por: Sung, Joseph J. Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cghn529npbju12jjd1c61h9v9e